CSI Market
Sign In | Register

Teva Pharmaceutical Industries Limited (TEVA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TEVA Annual Balance Sheets →
Quarterly balance sheet trends provide context on Teva Pharmaceutical Industries Limited's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent3,655.00
Cash & Short-term Investments3,655.00
Accounts receivable3,493.00
Inventories3,221.00
Disposal Group, Including Discontinued Operation, Assets, Current AS1,794.00
Other Current Assets563.00
Prepaid Expense, Current AS1,034.00
Total Current Assets13,760.00
Equipment/Property/Plant Net3,928.00
Goodwill net15,839.00
Intangible Assets3,447.00
Deferred Tax Assets, Net of Valuation Allowance, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent58.00
Discontinued operations, Noncurrent184.00
Other Assets, Noncurrent2,641.00
Total Assets39,857.00
Liabilities
Accounts Payable, Trade, Current2,721.00
Employee-related Liabilities, Current AC488.00
Debt, Current LI4,500.00
Other Liabilities, Current7,932.00
Taxes Payable0.00
Discontinued Operation, Liabilities5.00
Total Current Liabilities15,646.00
Long-term debt12,092.00
Total Long-term Debt12,092.00
Financial Instruments, Insurance, Noncurrent111.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Discontinued Operation, Noncurrent313.00
Other liabilities, Noncurrent3,938.00
Sales Reserves And Allowances3,707.00
Accrued Expenses2,616.00
Total Liabilities32,100.00
Stockholders' Equity
Common Stock Value59.00
Treasury Stock Value-4,128.00
Additional Paid In Capital Common Stock28,256.00
Retained Earnings / Accumulated Deficit-13,969.00
Accumulated Other Comprehensive Income-2,465.00
Other Equity-2,465.00
Common Stockholder's Equity7,753.00
Non-controlling interests & other4.00
Total Stockholder's Equity7,757.00
Liabilities & Stockholder's Equity39,857.00
4 historic quarters locked

Sign in to unlock the full Teva Pharmaceutical Industries Limited balance sheet history.

Sign In Create Free Account

About Teva Pharmaceutical Industries Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: July 29, 2026
  • Source: d118828d10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-323619

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.